Spherity Blog

FDA has been keeping its ear to the ground to understand the industry’s DSCSA readiness.

FDA grants large-scale exemption to trading partners on enhanced drug distribution security (EDDS) and related requirements.

The Louisiana Board surveyed DSCSA readiness (Aug–Sep 2024), a timely move ahead of FDA’s Stabilization Period ending Nov 27, 2024.

Read industry updates and key takeaways from the DSCSA Stabilization Period at the HDA Traceability Seminar.

FDA has granted a selective enforcement delay for small dispensers with the definition of ‘small’ being broader than in previous guidance.

ATP credentialing is essential for DSCSA compliance. Our partner Legisym ensures accuracy by curating data on 80K US pharmaceutical entities

Discover how Systech and Spherity partnered to help U.S. trading partners achieve seamless DSCSA compliance through secure, interoperable solutions.

Spherity first to complete compliance audit to OCI Digital Wallet Conformance Criteria to validate pharmaceutical Authorized Trading Partner

Spherity is honored as Digital Identity Solution of the Year 2025 by Enterprise Security Magazine, recognizing our impact and innovation.

Worried about DSCSA disruption? See 4 FDA violation patterns and how Spherity and Legisym enable automated ATP checks and secure product verification.

Spherity is honored as Digital Identity Solution of the Year 2025 by Enterprise Security Magazine, recognizing our impact and innovation.

Spherity is honored as Digital Identity Solution of the Year 2025 by Enterprise Security Magazine, recognizing our impact and innovation.

As co-chairs of the OCI’s Steering Committee, Georg Jürgens and David Kessler explained how OCI-specified credentials can support trading partners in meeting DSCSA requirements - sharing hands-on insights and lessons learned from real-world implementations.

Spherity is honored as Digital Identity Solution of the Year 2025 by Enterprise Security Magazine, recognizing our impact and innovation.

Spherity is honored as Digital Identity Solution of the Year 2025 by Enterprise Security Magazine, recognizing our impact and innovation.

Why centralized ATP repositories complicate DSCSA compliance - examining risks, misconceptions, and better approaches to Authorized Trading Partner verification.

Check out Chris' piece in Pharmaceutical Commerce’s June issue, where she shares how OCI’s work on credential standards is enabling interoperable DSCSA solutions across the pharma supply chain.

Spherity and Legisym partner to automate DSCSA Authorized Trading Partner (ATP) compliance. Discover our digital wallet and credential solution for US pharmaceutical trading partners.

The Spherity Credentialing Service is now integrated and available on the SAP Information Collaboration Hub for Life Sciences.